Home / Journals International Journal of Immunology / Immunomodulation and Suppression
Immunomodulation and Suppression
Submission Deadline: Sep. 30, 2015

This special issue currently is open for paper submission and guest editor application.

Join as Guest Editor Submit to Special Issue
Lead Guest Editor
School of Pharmaceutical Sciences, IFTM University (Institute of Foreign Trade and Management), Moradabad, Uttar Pradesh, India
Guest Editors
  • Lalit Singh
    Pharmacology, Sunder Deep Pharmacy College, GHAZIABAD, Uttar Pradesh, India
  • Roya Amirinejad
    Department of Molecular Genetics ,Tarbiat Modare University, Tehran, Iran
  • Malak Kotb
    School of Medicine and Health Sceinces, University of North Dakota, Grand Forks, North Dakota, USA
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=115). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.
Introduction
Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response". Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

Aims and Scope:

Immunomodulatory activity

1. Cancer
2. AIDS
3. New semi synthetic or isolated compound ACTIVITY
4. Interlukins
5. Vaccination
6. Plant extracts activity

Immunosuppression

1. Immunosuppressive activity of plants
2. Allergies Therapy
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186